BlackRock’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.2K Sell
17,778
-5,463
-24% -$9.89K ﹤0.01% 4997
2025
Q1
$47.2K Sell
23,241
-547
-2% -$1.11K ﹤0.01% 4882
2024
Q4
$142K Buy
23,788
+1,133
+5% +$6.78K ﹤0.01% 4637
2024
Q3
$221K Sell
22,655
-4,888
-18% -$47.7K ﹤0.01% 4457
2024
Q2
$564K Sell
27,543
-55,461
-67% -$1.14M ﹤0.01% 4266
2024
Q1
$3.75M Sell
83,004
-2,884
-3% -$130K ﹤0.01% 3736
2023
Q4
$4.05M Buy
85,888
+4,781
+6% +$226K ﹤0.01% 3697
2023
Q3
$3.28M Sell
81,107
-5,720
-7% -$232K ﹤0.01% 3771
2023
Q2
$9.25M Buy
86,827
+1,159
+1% +$124K ﹤0.01% 3385
2023
Q1
$25.6M Sell
85,668
-5,765
-6% -$1.72M ﹤0.01% 2790
2022
Q4
$31.4M Sell
91,433
-28
-0% -$9.62K ﹤0.01% 2738
2022
Q3
$17.3M Buy
91,461
+2,502
+3% +$473K ﹤0.01% 3062
2022
Q2
$18.8M Buy
88,959
+8,898
+11% +$1.88M ﹤0.01% 3059
2022
Q1
$26.8M Sell
80,061
-542
-0.7% -$181K ﹤0.01% 2923
2021
Q4
$26.2M Buy
80,603
+4,557
+6% +$1.48M ﹤0.01% 3061
2021
Q3
$36.9M Buy
76,046
+5,271
+7% +$2.56M ﹤0.01% 2828
2021
Q2
$32.9M Buy
70,775
+4,893
+7% +$2.28M ﹤0.01% 2942
2021
Q1
$45.5M Buy
65,882
+9,644
+17% +$6.66M ﹤0.01% 2640
2020
Q4
$41.6M Buy
56,238
+5,605
+11% +$4.14M ﹤0.01% 2536
2020
Q3
$35.1M Buy
50,633
+5,578
+12% +$3.87M ﹤0.01% 2448
2020
Q2
$38.2M Buy
45,055
+13,853
+44% +$11.7M ﹤0.01% 2375
2020
Q1
$11.2M Buy
31,202
+6,167
+25% +$2.21M ﹤0.01% 2890
2019
Q4
$5.85M Buy
25,035
+5,750
+30% +$1.34M ﹤0.01% 3408
2019
Q3
$2.17M Buy
19,285
+588
+3% +$66.2K ﹤0.01% 3672
2019
Q2
$3.28M Buy
18,697
+17,802
+1,989% +$3.12M ﹤0.01% 3590
2019
Q1
$142K Sell
895
-62
-6% -$9.84K ﹤0.01% 4264
2018
Q4
$59K Sell
957
-17
-2% -$1.05K ﹤0.01% 4407
2018
Q3
$120K Buy
974
+39
+4% +$4.81K ﹤0.01% 4362
2018
Q2
$137K Buy
+935
New +$137K ﹤0.01% 4343